Kerecis Selected to Present at the Northern Prime Minister Meeting

Kerecis Selected to Present at the Northern Prime Minister Meeting

ID: 350551

(firmenpresse) - REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND -- (Marketwired) -- 11/06/14 -- Kerecis Limited, the emerging leader in tissue-regeneration materials, will present at the Northern Future Forum in Helsinki November 7. The forum is the meeting of the prime ministers of the Nordic countries as well as of Estonia, Lithuania, Latvia and the United Kingdom.

Kerecis is one of two Icelandic companies selected to present at the forum. The Kerecis presentation will be part of the "how to boost innovation with research and education" segment of the meeting and will be chaired by the prime ministers of Sweden, Latvia and Iceland.



G. Fertram Sigurjonsson, President and CEO, Kerecis Limited

"The Northern Future Forum is a unique platform for prime ministers and upcoming company leaders to discuss topics that will shape the future of the societies in the northern hemisphere. We are proud to participate in that dialogue."



Kerecis develops tissue-regeneration biologic matrixes consisting of patented Omega3-containing fish skin. Production takes place in Kerecis' manufacturing facilities in Iceland. Biologic matrixes are materials made from human or animal tissue where the original material is intact, but all cells and antigenic materials have been removed. The Kerecis fish-skin material accelerates wound healing and enables tissue reconstruction.

This FDA-approved material offers advantages over existing human- and porcine-derived products, including improved manufacturing economics and a lower risk of disease transfer. Since it is derived from fish, the material is both kosher and halal compatible, eliminating cultural and religious constraints to usage, with equivalent or better clinical performance than alternative approaches.

The Kerecis technology has received U.S. patents, and has patents pending in multiple countries around the world. The materials are available in Iceland, Denmark, the UK, Turkey and several Middle East and Asian markets. Distributor inquiries are welcome. For more information, visit .







For further information, contact:
G. Fertram Sigurjonsson
President and CEO
Kerecis Limited
Phone (Iceland) +354-8494960
(U.S.) 703-879-6535
E-mail:

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Arch Therapeutics Reports Positive Preclinical Data From Study of AC5 Surgical Hemostatic Device(TM) in Animals Treated With the Antiplatelet Medications Plavix(R) (Clopidogrel) and Aspirin Miniaturized Ultrasound for Pain to Make International Debut at Medica 2014
Bereitgestellt von Benutzer: Marketwired
Datum: 06.11.2014 - 21:02 Uhr
Sprache: Deutsch
News-ID 350551
Anzahl Zeichen: 0

contact information:
Town:

REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND



Kategorie:

Alternative



Diese Pressemitteilung wurde bisher 259 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Kerecis Selected to Present at the Northern Prime Minister Meeting"
steht unter der journalistisch-redaktionellen Verantwortung von

Kerecis (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Kerecis Named Iceland's Fastest Growing Startup ...

REYKJAVIK, ICELAND -- (Marketwired) -- 05/23/17 -- The Icelandic Growth Consortium today named Kerecis the country's fastest growing startup. Kerecis is the creator, manufacturer and patent holder of revolutionary fish-skin-based therapeutic pr ...

Alle Meldungen von Kerecis



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z